trending Market Intelligence /marketintelligence/en/news-insights/trending/p2dmnpub8ybibcazj88aga2 content esgSubNav
In This List

Chimerix chief strategy, commercial officer resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Chimerix chief strategy, commercial officer resigns

Chimerix Inc. said Linda Richardson resigned as chief strategy and commercial officer for personal reasons, effective June 27.

Durham, N.C.-based Chimerix develops treatments that address unmet medical needs in the U.S.